Bonnie S. Glisson

28.4k total citations · 5 hit papers
275 papers, 14.8k citations indexed

About

Bonnie S. Glisson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Bonnie S. Glisson has authored 275 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 193 papers in Oncology, 105 papers in Pulmonary and Respiratory Medicine and 84 papers in Otorhinolaryngology. Recurrent topics in Bonnie S. Glisson's work include Lung Cancer Research Studies (96 papers), Head and Neck Cancer Studies (82 papers) and Lung Cancer Treatments and Mutations (75 papers). Bonnie S. Glisson is often cited by papers focused on Lung Cancer Research Studies (96 papers), Head and Neck Cancer Studies (82 papers) and Lung Cancer Treatments and Mutations (75 papers). Bonnie S. Glisson collaborates with scholars based in United States, South Korea and China. Bonnie S. Glisson's co-authors include William H. Morrison, Randal S. Weber, Warren E. Ross, Helmuth Goepfert, Arlene A. Forastiere, Moshe Maor, Jay S. Cooper, Andy Trotti, John F. Ensley and John A. Ridge and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Bonnie S. Glisson

273 papers receiving 14.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

2003 2.3k citations Randal S. Weber, William H. Morrison et al. profile →
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

2012 835 citations Randal S. Weber, William H. Morrison et al. Journal of Clinical Oncology profile →
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

2019 616 citations Triparna Sen, B. Leticia Rodriguez et al. Cancer Discovery profile →
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

2009 531 citations Adam S. Garden, Bonnie S. Glisson et al. Journal of Clinical Oncology profile →
Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.

1984 396 citations Bonnie S. Glisson et al. profile →

Peers

Countries citing papers authored by Bonnie S. Glisson

Since Specialization

Citations

This map shows the geographic impact of Bonnie S. Glisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bonnie S. Glisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bonnie S. Glisson more than expected).

Fields of papers citing papers by Bonnie S. Glisson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bonnie S. Glisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bonnie S. Glisson. The network helps show where Bonnie S. Glisson may publish in the future.

Co-authorship network of co-authors of Bonnie S. Glisson

This figure shows the co-authorship network connecting the top 25 collaborators of Bonnie S. Glisson. A scholar is included among the top collaborators of Bonnie S. Glisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bonnie S. Glisson. Bonnie S. Glisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma 2023 ·Journal of Clinical Oncology ·Renata Ferrarotto, Luana Guimarães de Sousa, Lei Feng, Frank E. Mott, George R. Blumenschein, Mehmet Altan, Diana Bell, (unknown), Kaiyi Li, Mario L. Marques‐Piubelli, (unknown), Jason M. Johnson, Yoshitsugu Mitani, Myrna C. B. Godoy, Anna Lee, Michael E. Kupferman, Ehab Y. Hanna, Bonnie S. Glisson, Yasir Y. Elamin, Adel K. El‐Naggar	23
2	Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial 2021 ·Advances in Therapy ·Renata Ferrarotto, Luana Guimarães de Sousa, Yun Qing, Diana Kaya, Bettzy Stephen, (unknown), Diana Bell, Shubham Pant, Apostolia M. Tsimberidou, Filip Jankú, George Blumenschein, Bonnie S. Glisson, Jordi Rodón, Sarina A. Piha‐Paul, J. Jack Lee, Michael K. Wong, Charles Lu, Funda Meric‐Bernstam, Aung Naing	9
3	Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation 2021 ·Cancer ·Theresa Guo, (unknown), Christopher M. K. L. Yao, Kimberley L. Kiong, (unknown), (unknown), J. Jack Lee, Amy C. Moreno, Steven J. Frank, David I. Rosenthal, Bonnie S. Glisson, Renata Ferrarotto, Frank E. Mott, Faye M. Johnson, Jeffrey N. Myers	7
4	Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified 2021 ·Cancer ·Luana Guimarães de Sousa, (unknown), (unknown), (unknown), Maria Laura Rubin, Clark R. Andersen, Whitney E. Lewis, (unknown), Diana Kaya, Adel K. El‐Naggar, Ehab Y. Hanna, Bita Esmaeli, Steven J. Frank, Diana Bell, Bonnie S. Glisson, Jordi Rodón, Funda Meric‐Bernstam, J. Jack Lee, Renata Ferrarotto	11
5	Role of induction chemotherapy for oral cavity squamous cell carcinoma 2021 ·Cancer ·Ahmed S. Abdelmeguid, Natalie L. Silver, Mongkol Boonsripitayanon, Bonnie S. Glisson, Renata Ferrarotto, G. Brandon Gunn, Jack Phan, Ann M. Gillenwater, Ehab Y. Hanna	13
6	The tumor immune contexture of salivary duct carcinoma 2021 ·Head & Neck ·Gustavo Schvartsman, Diana Bell, M. Laura Rubin, Michael T. Tetzlaff, Ehab Y. Hanna, J. Jack Lee, Randal S. Weber, Jack Phan, Bonnie S. Glisson, Renata Ferrarotto	10
7	Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck 2021 ·Head & Neck ·Samantha Tam, (unknown), Xiaoning Luo, Bonnie S. Glisson, Renata Ferrarotto, Faye M. Johnson, Frank E. Mott, Maura L. Gillison, Charles Lu, Xiuning Le, George R. Blumenschein, Michael K. Wong, David I. Rosenthal, Priyadharsini Nagarajan, Adel K. El‐Naggar, (unknown), Randal S. Weber, Jeffrey N. Myers, Neil D. Gross	3
8	Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors 2020 ·Clinical Cancer Research ·Bonnie S. Glisson, Rom S. Leidner, Robert L. Ferris, John D. Powderly, Naiyer A. Rizvi, Bhumsuk Keam, Reva Schneider, Sanjay Goel, James Ohr, (unknown), Yanan Zheng, Steven Eck, Matthew Gribbin, Katie Streicher, Danielle M. Townsley, Sandip Pravin Patel	63
9	Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets 2020 ·Clinical Cancer Research ·Renata Ferrarotto, Yoshitsugu Mitani, Daniel J. McGrail, Kaiyi Li, Tatiana V. Karpinets, Diana Bell, Steven J. Frank, Xingzhi Song, Michael E. Kupferman, Bin Liu, J. Jack Lee, Bonnie S. Glisson, Jianhua Zhang, Jon C. Aster, Shiaw‐Yih Lin, P. Andrew Futreal, John V. Heymach, Adel K. El‐Naggar	87
10	Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results 2020 ·Clinical Cancer Research ·Renata Ferrarotto, Diana Bell, Maria Laura Rubin, Katherine A. Hutcheson, Jason M. Johnson, Ryan P. Goepfert, Jack Phan, Yasir Y. Elamin, (unknown), Carla L. Warneke, Amy C. Hessel, Adam S. Garden, Jeffrey N. Myers, Faye M. Johnson, J. Jack Lee, Andrew G. Sikora, Maura L. Gillison, Bonnie S. Glisson, Neil D. Gross	82
11	Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer breakdown → 2019 ·Cancer Discovery ·Triparna Sen, B. Leticia Rodriguez, Limo Chen, Carminia Maria Della Corte, Naoto Morikawa, Junya Fujimoto, Sandra Cristea, Thuyen Nguyen, Lixia Diao, Lerong Li, You-Hong Fan, Yongbin Yang, Jing Wang, Bonnie S. Glisson, Ignacio I. Wistuba, Julien Sage, John V. Heymach, Don L. Gibbons, Lauren A. Byers	616
12	Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study 2019 ·Clinical Cancer Research ·Daniel Morgensztern, Benjamin Besse, Laurent Greillier, Rafael Santana-Dávila, Neal Ready, Christine L. Hann, Bonnie S. Glisson, Anna F. Farago, Afshin Dowlati, Charles M. Rudin, Sylvestre Le Moulec, Satwant Lally, Sreeni Yalamanchili, Jürgen Wolf, Ramaswamy Govindan, David P. Carbone	229
13	Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma 2019 ·Oral Oncology ·Roberto Carmagnani Pestana, Melody Becnel, Maria Laura Rubin, (unknown), (unknown), Jack Phan, Ehab Y. Hanna, Diana Bell, Bonnie S. Glisson, Jason M. Johnson, J. Jack Lee, Renata Ferrarotto	41
14	Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer 2015 ·Clinical Cancer Research ·Renata Ferrarotto, (unknown), Suk Young Yoo, Pan Tong, Uma Giri, Shaohua Peng, John D. Minna, Luc Girard, Yuehong Wang, Liguang Wang, Lerong Li, Lixia Diao, David H. Peng, Don L. Gibbons, Bonnie S. Glisson, John V. Heymach, Jing Wang, Lauren A. Byers, Faye M. Johnson	40
15	Prognostic value of p16 expression in Epstein‐Barr virus–positive nasopharyngeal carcinomas 2015 ·Head & Neck ·Wen Jiang, Paul Chamberlain, Adam S. Garden, Betty Y.S. Kim, (unknown), (unknown), Diana Bell, G. Brandon Gunn, Clifton D. Fuller, David I. Rosenthal, Beth M. Beadle, Steven J. Frank, William H. Morrison, Adel K. El‐Naggar, Bonnie S. Glisson, Erich M. Sturgis, Jack Phan	29
16	A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma 2014 ·Molecular Cancer Therapeutics ·Tuhina Mazumdar, Lauren A. Byers, Patrick Kwok Shing Ng, Gordon B. Mills, Shaohua Peng, Lixia Diao, You-Hong Fan, Katherine Stemke‐Hale, John V. Heymach, Jeffrey N. Myers, Bonnie S. Glisson, Faye M. Johnson	66
17	A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck 2012 ·Clinical Cancer Research ·Carol M. Lewis, Bonnie S. Glisson, Lei Feng, Fiona Wan, Ximing Tang, Ignacio I. Wistuba, Adel K. El‐Naggar, David I. Rosenthal, Mark S. Chambers, Robert A. Lustig, Randal S. Weber	131
18	Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody 2011 ·Molecular Cancer Therapeutics ·Dong Hoon Shin, Hye‐Young Min, Adel K. El‐Naggar, Scott M. Lippman, Bonnie S. Glisson, Ho‐Young Lee	37
19	Safety and pharmacokinetics of first-line amg 479 (mab to igf1r) or amg 102 (mab to hgf/sf) with platinum-based chemotherapy in extensive-stage small cell lung cancer (sclc) 2010 ·Annals of Oncology ·Paul Lorigan, J.C. Soria, Joan Stephenson, (unknown), R. Gervais, (unknown), Ian McCaffery, (unknown), Jesse McGreivy, Bonnie S. Glisson	6
20	Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial 2009 ·Journal of Clinical Oncology ·Merrill S. Kies, Floyd Christopher Holsinger, J. Jack Lee, William N. William, Bonnie S. Glisson, Heather Lin, Jan S. Lewin, Lawrence E. Ginsberg, (unknown), Erminia Massarelli, Lauren A. Byers, Scott M. Lippman, Waun Ki Hong, Adel K. El‐Naggar, Adam S. Garden, Vassiliki A. Papadimitrakopoulou	187

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact